Clinical trials

Recherche d’études cliniques

Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.

Réinitialiser

Études cliniques 3370

Étude / NCT ⇅ Molécule ⇅ Maladie ⇅ Phase ⇅ Statut ⇅ Résultat ⇅ Sponsor ⇅ Pays / centres ⇅ Période ⇅ Détail
NCT06291220
453 Ph1 CLL — A Study Assessing Adverse Event and How Oral ABBV-453 Mov…
Obinutuzumab Cancer Phase 1 ACTIVE_NOT_RECRUITING En attente / non publié Hoffmann-La Roche United States, Australia, Germany, Israel, Italy · At… 2025-01-27 → 2027-07 Ouvrir
NCT07714538
BRAVE — Breath Research Narrow Validation for Gastrointestinal Cancer D…
BRAVE — Breath Research Narrow Va… Cancer À vérifier RECRUITING En attente / non publié Imperial College London United Kingdom · Imperial College Healthcare NHS Trus… 2026-07-26 → 2028-08-02 Ouvrir
NCT07622992
OPTI-OAGB — Preoperative Optimization With Tirzepatide, Ketogenic Diet,…
OPTI-OAGB — Preoperative Optimiza… Hypertension À vérifier NOT_YET_RECRUITING En attente / non publié Mario Musella MD Italy · University Federico II of Naples, Naples, Ita… 2027-01-01 → 2029-12-01 Ouvrir
NCT07045363
E-CHARM — Embedded Community-based Heart-Age Risk Education Trial in Ci…
E-CHARM — Embedded Community-base… Hypertension Non applicable COMPLETED En attente / non publié Duke Kunshan University China · Tinglin Community Health Center, Suzhou, China 2025-08-19 → 2026-09-01 Ouvrir
NCT07784621
A Phase 1 Clinical Trial to Evaluate the Safety and the Pharmacokinetic…
Losartan (COZZAR®) Hypertension Phase 1 NOT_YET_RECRUITING En attente / non publié Huons Co., Ltd. South Korea · Seoul National University Hospital, Seo… 2026-10 → 2027-02 Ouvrir
NCT06771024
CPEPCD — Community Physical Exercise Program in Chronic Disease
CPEPCD — Community Physical Exerc… Hypertension Non applicable NOT_YET_RECRUITING En attente / non publié Associação para o Desenvolvimento… Portugal · Algarve Biomedical Center, Faro, Portugal 2026-10 → 2027-04 Ouvrir
NCT05503953
Phase III Study to Evaluate the Efficacy and Safety of AGSAVI in Patien…
AGSAVI Hypertension Phase 3 COMPLETED En attente / non publié Ahn-Gook Pharmaceuticals Co.,Ltd South Korea · AhnGook, Seoul, South Korea 2022-09-13 → 2025-06-10 Ouvrir
NCT07486375
Self-Management App for Blood Pressure and Well-Being in Postpartum Wom…
Self-Management App for Blood Pre… Hypertension Non applicable COMPLETED En attente / non publié National Cheng-Kung University Ho… Taiwan · National Cheng Kung University Hospital, Tai… 2023-02-15 → 2023-12-25 Ouvrir
NCT03799653
A Prospective Nurse Cohort Study in Xiamen, China
A Prospective Nurse Cohort Study … Hypertension À vérifier RECRUITING En attente / non publié The First Affiliated Hospital of … China · The First Affiliated Hospital of Xiamen Unive… 2019-03-20 → 2028-12-31 Ouvrir
NCT02880631
BAROSTIM THERAPY™ In Resistant Hypertension
BAROSTIM NEO™ System Hypertension À vérifier RECRUITING En attente / non publié CVRx, Inc. Germany, Netherlands · Asklepios Klinik Altona, Hambu… 2016-12-13 → 2027-07 Ouvrir
NCT07665034
IRE-HT — Isometric Resistance Exercise on Accelerated Atherosclerosis i…
IRE-HT — Isometric Resistance Exe… Hypertension Non applicable RECRUITING En attente / non publié Chinese University of Hong Kong Hong Kong · The Chinese University of Hong Kong, Depa… 2025-04-16 → 2027-12-30 Ouvrir
NCT07784647
ACTION — A Combination Triple Pill Implementation Strategy for Blood Pr…
ACTION — A Combination Triple Pil… Hypertension À vérifier COMPLETED En attente / non publié Imperial College London Nigeria, Sri Lanka · RemediumOne, Colombo, Sri Lanka … 2026-04-01 → 2026-08-07 Ouvrir
NCT06150560
A Study of Angiotensin-II Receptor Blocker on Cardiovascular Remodeling…
Losartan Hypertension Phase 3 RECRUITING En attente / non publié Mayo Clinic United States · Mayo Clinic in Rochester, Rochester, … 2024-04-01 → 2028-06-01 Ouvrir
NCT05968430
Open-Label Extension (OLE) Study to Assess Safety, Efficacy, and Tolera…
lorundrostat Hypertension Phase 3 ACTIVE_NOT_RECRUITING En attente / non publié Mineralys Therapeutics Inc. United States, Australia, Bulgaria, Canada, France, G… 2023-07-14 → 2027-05 Ouvrir
NCT01679132
BAROSTIM NEO Hypertension Pivotal Trial
BAROSTIM NEO System and Medical M… Hypertension Non applicable COMPLETED En attente / non publié CVRx, Inc. United States · Allegheny General Hospital, Pittsburg… 2013-04-12 → 2025-07-23 Ouvrir
NCT07594769
A Study to Compare the Blood Levels of Two Dosage Formulations of the S…
ODT2 Test formulation Migraine Phase 1 COMPLETED En attente / non publié Pfizer Belgium · Pfizer Clinical Research Unit - Brussels, B… 2026-05-11 → 2026-09-01 Ouvrir
NCT03694626
Objectively Diagnose and Monitor Treatment of Light Sensitivity
Pupillography Migraine Non applicable RECRUITING En attente / non publié Randy Kardon United States · University of Iowa Health Care, Iowa … 2019-07-11 → 2028-01-01 Ouvrir
NCT06701526
A Trial of Eptinezumab in Participants With Migraine and Insufficient R…
Eptinezumab Migraine Phase 4 COMPLETED En attente / non publié H. Lundbeck A/S United States · Albany Medical College, Albany, Unite… 2024-12-18 → 2026-09-02 Ouvrir
NCT06625060
MERANTI — A Study to Evaluate IPN10200 Safety and Efficacy in the Preve…
Corabotase Migraine Phase 2 ACTIVE_NOT_RECRUITING En attente / non publié Ipsen United States, Australia, Brazil, Canada, Czechia, Fr… 2024-10-10 → 2027-10-31 Ouvrir
NCT06806293
ATO MM — Study of Oral Atogepant to Assess Adverse Events and Change in…
Atogepant Migraine Phase 3 ACTIVE_NOT_RECRUITING En attente / non publié AbbVie China, Czechia, Germany, Hungary, Italy, Japan, Polan… 2025-02-10 → 2027-07 Ouvrir
NCT06891118
SGB-RCM — Stellate Ganglion Blockade for Refractory Chronic Migraine
Procedure/Surgery: Ultrasound-Gui… Migraine Non applicable COMPLETED En attente / non publié Ankara City Hospital Bilkent Turkey (Türkiye) · Health Sciences University, Ankara… 2024-03-06 → 2025-12-30 Ouvrir
NCT06848166
CHROME — CHROnic Migraine Embolization
liquid embolic agent SQUID 12, li… Migraine Non applicable RECRUITING En attente / non publié Vedanta University Clinic Kyrgyzstan · Vedanta University Clinic, Bishkek, Kyrg… 2024-10-17 → 2029-05 Ouvrir
NCT07816367
A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the …
Elismetrep Migraine Phase 3 NOT_YET_RECRUITING En attente / non publié Kallyope Inc. United States · Accellacare - Cary (Cary Medical Grou… 2026-09 → 2027-12 Ouvrir
NCT06241313
ATO ACUTE — Study of Oral Atogepant Tablets to Assess Safety and Effica…
Atogepant Migraine Phase 3 COMPLETED En attente / non publié AbbVie Belgium, China, Czechia, Germany, Hungary, Italy, Jap… 2024-03-25 → 2026-08-11 Ouvrir
NCT05690737
Tai Chi for the Prophylaxis of Episodic Migraine: the Efficacy Examinat…
Standard prophylactic medication Migraine Non applicable COMPLETED En attente / non publié The Hong Kong Polytechnic Univers… Hong Kong · The Hong Kong Polytechnic University, Hon… 2023-09-11 → 2026-06-30 Ouvrir